Now 78% of scientists say AI will speed drug discovery this year: Signal Survey
A year ago, Endpoints Signal surveyed almost 1,500 biopharma insiders about the very near-term prospects of AI accelerating drug discovery. Scientists, interestingly, were the most …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Post-Makary FDA wins over investors, but not scientists or Big Pharma: Signal Survey October 27, 2026
Anthropic's latest biotech buy is a one-man stealth startup run by a pseudonymous Twitter poster
Backed by Amish and Mennonites, a new kind of gene therapy company takes shape
Treasury's COINS rule draft would narrow the path for China biotech dealmaking, experts say
Source link







